Added to YB: 2025-11-18
Pitch date: 2025-11-14
NOVO-B.CO [neutral]
Novo Nordisk A/S
-21.49%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.1T
Pitch Price
DKK 301.73
Price Target
N/A
Dividend
4.94%
EV/EBITDA
7.46
P/E
10.29
EV/Sales
3.74
Sector
Pharmaceuticals
Category
value
Show full summary:
Theodosian Capital | Stocks Update 14/11/2025 - NOVOB – Que Metsera, sera
NOVO-B.CO (update): Withdrew from $10bn Metsera bid (stock up on news) after 4 guidance downgrades this year. Raised €4bn via bond sale to fund $5bn Akero acquisition. Trades 12.9x 2026 P/E, 3.9% yield - material re-rating possible if challenges addressed.
Read full article (1 min)